Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
4-5 Charnwood Court,, Heol Billingsley, Parc Nantgarw
Cardiff
CF15 7QZ
UK
Telephone: +44 1443848585
E-mail: shannon.mason@wales.nhs.uk
NUTS: UK
Internet address(es)
Main address: http://nwssp.nhs.wales/ourservices/procurement-services/
Address of the buyer profile: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Faecal Immunochemical Testing (FIT) to provide support for patients identified with symptoms associated with bowel cancer.
Reference number: PHW-STA-555
II.1.2) Main CPV code
33696500
II.1.3) Type of contract
Supplies
II.1.4) Short description
The provision of goods and services to support faecal immunochemical testing (FIT) from Alpha Laboratories to support All Wales testing for patients identified in primary and secondary care as having symptoms associated with bowel cancer.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
298 880.00
GBP
II.2) Description
II.2.2) Additional CPV code(s)
33696500
II.2.3) Place of performance
NUTS code:
UKL
Main site or place of performance:
Public Health Wales, NHS Trust.
II.2.4) Description of the procurement
The provision of goods and services to support faecal immunochemical testing (FIT) from Alpha Laboratories to support All Wales testing for patients identified in primary and secondary care as having symptoms associated with bowel cancer.
NHS Wales Shared Service Partnership on behalf of Public Health Wales NHS Trust wish to inform the market that due to consequences of the global pandemic, Covid-19, they are awarding a contract for the provision of goods and services to support Faecal Immunochemical Testing (FIT) from Alpha Laboratories to support All Wales testing for patients identified in primary and secondary care as having symptoms associated with bowel cancer.
The existing Bowel Screen Wales contract with Alpha Laboratories for Provision of Faecal Immunochemical Testing Analysers and Consumables was due to end in November 2021, and it was intended to go to market for the supply of Symptomatic and Screening Fit as one tender.
However, due to the outbreak of Covid-19 in 2020 and the subsequent suspension of routine hospital services and Screening across Wales; The Screening Division was approached to provide testing for patients presenting in Primary/Secondary care with symptoms of bowel cancer. Prior to Covid-19 these patients would be referred to Endoscopy. To ensure that urgent suspected cancers were identified during the pandemic, the decision was made to utilise Screenings existing FIT testing capability and service model.
To establish this service at short notice, the Screening Laboratory have entered contract with Alpha, the primary supplier of FIT to the Bowel Screening Wales Programme.
Appointing Alpha Laboratories as the single supplier was the most considered and beneficial approach to deliver the service and support the wider NHS needs in Wales. Due to the existing MSC arrangements in place with Alpha Laboratories for FIT Screening, the choice of this supplier would ensure: - Continuity of supply. - Compatibility with existing equipment and testing methodologies. - Reduced need for training - Existing patient material can be used to ensure patients complete their test correctly.
The Public Health Wales Screening Division do not have the resources to undertake a competitive procurement process through an open OJEU procedure currently due to supporting various screening and Covid activity.
In order to enable the provision of the Faecal Immunochemical Testing (FIT), to support all Wales testing for patients identified as having symptoms associated with bowel cancel, Public Health Wales would like to inform the market that under Regulation 32 (2) (C)of the Public Contracts Regulation 2015(PCR’s) as detailed in UK Government guidance PPN01/20 they are awarding the contract to Alpha Laboratories. The trust has met the criteria for awarding a contract under this regulation due to the disruption to patient care and services that COVID-19 poses to the population of Wales.
II.2.5) Award criteria
Price
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
II.2.14) Additional information
Aligning the FIT symptomatic workload with the contract already in place for the FIT screening is the only practical option to provide continued patient care. Going forward, both elements will be combined in the procurement of the existing contract for renewal.
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Award of a contract without prior publication of a call for competition
Justification for selected award procedure:
The procurement falls outside the scope of application of the Directive
Explanation
In order to enable the provision of the Faecal Immunochemical Testing (FIT), to support all Wales testing for patients identified as having symptoms associated with bowel cancel, Public Health Wales would like to inform the market that under Regulation 32 (2) (C)of the Public Contracts Regulation 2015(PCR’s) as detailed in UK Government guidance PPN01/20 they are awarding the contract to Alpha Laboratories. The trust has met the criteria for awarding a contract under this regulation due to the disruption to patient care and services that COVID-19 poses to the population of Wales.
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
Notice number in the OJ S:
2021/S 000-008738
Section V: Award of contract
Contract No: PHW-STA-555
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
01/04/2021
V.2.2) Information about tenders
Number of tenders received: 1
Number of tenders received from SMEs: 0
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 1
Number of tenders received by electronic means: 1
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Alpha Laboratories Ltd
40 Parham Drive, Eastleigh
Hampshire
SO504NU
UK
Telephone: +44 02380487239
NUTS: UKJ3
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 298 880.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
(WA Ref:131351)
VI.4) Procedures for review
VI.4.1) Review body
High Court
Royal Courts of Justice, The Strand
London
WC2A 2LL
UK
Telephone: +44 2079477501
VI.4.3) Review procedure
Precise information on deadline(s) for review procedures:
NHS Wales Shared Services Partnership on behalf of Public Health Wales Trust will allow a minimum 10 calendar day standstill period between notifying the award decision and awarding the contract.
VI.5) Date of dispatch of this notice
05/05/2023